Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IXP | Ann: Removal from Official Quotation | 22/06/18 | 0 | 1.5K | |||
|
|||||||
IXP | Ann: Net Tangible Asset Backing | 21/06/18 | 0 | 866 | |||
|
|||||||
IXP | Ann: Distribution | 19/06/18 | 0 | 526 | |||
|
|||||||
IXP | Ann: Suspension from Offical Quotation - Various ETFs | 15/06/18 | 0 | 511 | |||
|
|||||||
IXP | Ann: Net Tangible Asset Backing | 14/06/18 | 0 | 518 | |||
|
|||||||
IXP | Ann: Distribution Dates | 12/06/18 | 0 | 512 | |||
|
|||||||
IXP | Ann: Number of Outstanding iShares Units | 07/06/18 | 0 | 465 | |||
|
|||||||
IXP | Ann: Net Tangible Asset Backing | 07/06/18 | 0 | 547 | |||
|
See All Discussions